WebFeb 1, 2024 · Cetuximab may cause a serious side effect called an infusion reaction. This can be life-threatening and requires immediate medical attention. Tell your doctor or nurse right away if you have a fever, chills, trouble with breathing, lightheadedness, fainting, or chest pain within a few hours after you receive it. WebObjectives: Cetuximab, a chimeric monoclonal antibody, is the only targeted therapy approved for squamous cell carcinoma of the head and neck (SCCHN). Infusion …
High incidence of cetuximab-related infusion reactions in
WebSymptoms can include trouble with breathing (including tightening of the airways, wheezing, or hoarseness), low blood pressure, shock, loss of consciousness, and/or heart attack. … WebNov 1, 2012 · Severe infusion reactions with cetuximab were reported in fewer than 3% of patients during clinical trials, and these reactions were rarely fatal (<1 in 1000 reactions). 2 The recommended management for infusion reactions is pretreatment with antihistamines; however, 90% of severe infusion reactions occur with the first cetuximab dose despite ... meyle parts any good fiesta
Management and Preparedness for Infusion and Hypersensitivity Reactions …
WebJun 20, 2007 · 9097 Background: Cetuximab is a chimeric (mouse/human) IgG1 monoclonal antibody against the epidermal growth factor receptor and is approved for use in patients (pts) with colorectal cancer and head and neck squamous cell carcinoma. Hypersensitivity reactions caused by cetuximab (C-HSR) have been reported; … WebAbstract Introduction: Cetuximab is a chimeric mouse-human (30:70) IgG1 monoclonal antibody that competitively inhibits the binding of epidermal growth factor. Cetuximab is … WebWe investigated the hypothesis that severe hypersensitivity reactions occurring during the initial infusion of cetuximab are mediated by preexisting IgE antibodies against … meyler elementary school website